#MEAction and Long COVID Justice Issue Press Statement about NIH Failure of Long COVID

#MEAction and Long COVID Justice issued a press statement yesterday about our communities’ deep concerns regarding the rollout of RECOVER’s clinical trials for Long COVID. 

As studies show half of the Long COVID community meets the diagnostic criteria for ME/CFS – and our core symptoms overlap – RECOVER’s research has major implications for our community. 

In the press release, we wrote about the great need to trial pharmacological drugs that have already shown promise in the ME/CFS community. Instead, the NIH is trialing brain games that cause cognitive PEM, graded exercise and meditation.

“It’s fiscally irresponsible to be spending millions of limited funds on soft therapies like meditation and brain training when there are over 50 pharmacological options waiting to be trialed,” said Ben HsuBorger, #MEAction Advocacy Director. “RECOVER needs to immediately course correct and begin implementing the recommendations of the patient experts and post-viral research community.”  

“For the past three years, the Long COVID and ME/CFS communities have repeatedly and clearly communicated the research priorities needed to make RECOVER a success, and they have been summarily ignored resulting in our current situation: only a handful of worthwhile trials coming down the pike after RECOVER has spent close to $1 billion on observational studies. Our communities have continuously called for RECOVER to set up a process that is accountable to the patient community at every level where patient advocates are equal partners. NIH routinely says it values the patient voice, but its actions have not matched its words.

“The RECOVER Initiative — and all NIH research on Long COVID — must be directly based on a strategic plan for research created by experts in infection-associated chronic illness, including representative patient advocates,” said JD Davids, Co-Director of Long COVID Justice and Strategies for High Impact. “This would avoid the mess we found ourselves in now where researchers are launching trials that are ignorant of the core symptoms of Long COVID or the most promising treatments to address them, despite concerted input from dedicated patient advocates.”



Latest News

blue rectangle image with the NIH logo in the top left hand corner. the words: NIH MECFS Research Roadmap Update Public comments open until March 8th appear in the middle of the image. the meaction logo is in the bottom right hand corner.

NIH ME/CFS Research Roadmap Update–Public Comment Period Now Open

The NIH ME/CFS Research Roadmap public comment period is open now with a deadline of March 8th.  #MEAction is a member of the ME/CFS Research Roadmap Working Group and for the past several months we have been advocating on behalf of this community within this group. Our Executive Director, Laurie Jones, served on the nervous

Read More »
a rectangle image with multiple small hearts in the corners. The words, Valentine's Day Interview with Jamison Hill and Book Promotion. The cover of the book is next to the words. The #MEAction logo at the bottom.

Valentine’s Day Interview with Jamison Hill & Book Promotion

We are excited to bring you a special Valentine’s Day promotion of Jamison Hill’s most recent book, Something’s Wrong with Micah.  #MEAction had the pleasure of having a Twitter chat with Jamison when his memoir When Force Meets Fate came out. We now get to bring this Q&A about his newest book to you. Jamison

Read More »
on a red sparkly rectangle image. The words "#MEAction's Volunteer Program Revamped!" are written in an arcade/game font. Sign-Up Today! The #MEAction logo in the bottom right corner

#MEAction’s Volunteer Program Revamped

Exciting news: #MEAction revamped our volunteer program for the new year! We are honored to have wonderful volunteers including people with ME, Long Covid, and other associated conditions as well as our caregivers, allies, and wider communities. Volunteering with #MEAction can and does make all the difference. We invite you to join our program! Our

Read More »
Scroll to Top